Brad Pentelute, PhD

Brad Pentelute is Professor of Chemistry at the Massachusetts Institute of Technology, an original co-founder of Decoy Therapeutics, and Chair of its Scientific Advisory Board. His research spans peptide and protein chemistry, intracellular delivery, and the discovery of selective binders for therapeutic targets. His laboratory pioneered automated flow technologies that compress the time required to design, build and test new peptide therapeutics.